Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07654751 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

Name: A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically — clinical trial record (NCT07654751)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorJanssen Research & Development, LLC

Started2026-08-07

View on ClinicalTrials.gov ↗

The purpose of this post-marketing study is to assess the amount of guselkumab in breast milk of lactating women receiving guselkumab as part of their standard clinical care provided by their treating physician, for any of the approved indications.

Amendment history 1 change detected by DataLookout

2026-08-29

Recruitment opened

Trial Details

NCT Number	NCT07654751
Lead Sponsor	Janssen Research & Development, LLC
Conditions	Psoriasis, Colitis, Ulcerative, Crohn Disease, Arthritis, Psoriatic
Enrollment	10 participants
Start Date	2026-08-07
Primary Completion	2027-08-31 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-28